BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 18, 2004
View Archived Issues
Excavated American, British, Dutch Avian Influenza Molecules Explicate 1918-19 Worldwide Human Pandemic
Read More
CollaGenex's Periostat Shown Effective In Rosacea Phase III
Read More
Other News To Note
Read More
Cortex's Ampakine CX516 Fizzles, But More Potent Ones In Pipeline
Cortex Pharmaceuticals Inc.'s CX516 for mild cognitive impairment failed to meet its primary endpoint in a Phase IIb trial, although a subset of patients with the worst memory trouble showed improvement over placebo. (BioWorld Today)
Read More
Anticipating Greater Spending For Trials, BioCryst Brings In $21.4M
Read More